Lv6
2606 积分 2022-11-30 加入
Molecular strategies in BRAF targeting: advances in patents, structure activity relationship and future prospects
7小时前
求助中
A new BRAF inhibitor breaks resistance barriers
7小时前
待确认
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
12天前
已完结
Targeting MEK in cancer and beyond: mechanistic insights and therapeutic opportunities
12天前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
15天前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
15天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
19天前
已完结
Pirfenidone in patients with idiopathic pulmonary fi brosis (CAPACITY): two randomised trials
19天前
已完结
The pivotal PYNNACLE phase 2 trial assessing rezatapopt, a selective p53 reactivator, in patients with advanced or metastatic solid tumors harboring a TP53 Y220C mutation: Interim analysis of patients with ovarian cancer
20天前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
20天前
已完结
皖公网安备34019202002308
